Bioinformatics Scientist

---

Job description

NuProbe USA is hiring two NGS Bioinformatics Scientists for its Houston (TX) location.

NuProbe is the US-based R&D subsidiary of NuProbe Global, a company devoted to the development of novel non-invasive DNA and RNA diagnostic assays.

Currently, NuProbe has several products based on NGS, qPCR, and sanger technologies. The Innovation team is developing new technologies based on NGS and qPCR for next stage products and services. The successful candidate will have the opportunity to join NuProbe, working under the guidance of Innovation team lead to contribute to the new technology development.

Primary Responsibilities

• (30% - 50%) Bioinformatics, NGS Data Analysis (Python, MATLAB)
• (50% - 70%) Leading projects and performing wet lab experiments including, but not limited to NGS library preparation, sequencing, PCR, qPCR, and nucleic acid extraction

EDUCATION & EXPERIENCE REQUIREMENT

• PhD or postdoc in Biology, Biochemistry, or related field
• Relevant bioinformatics experience in NGS and genomics data analysis, as well as using bioinformatics databases
• Familiar with Python or MATLAB
• Familiar with NGS library preparation, PCR, qPCR relative wetlab skills
• 1 - 3 years of relevant wet-lab and dry-lab experience
• Leadership or potential leadership, teamwork
• We are looking for a highly motivated person, with the enthusiasm necessary to learn and grow with us

BENEFITS

• Contribute to the success of a growing reality
• Competitive salary based on experience + benefits
• Promotion in 1-2 years for successful candidates
• 20% targeted year-end perfomanced based bonus
• ESOP Stock Options
• Company benefits (medical, dental, unlimited PTO, 401k, etc.)
• Professional growth: At NuProbe, we believe in people and we foster professional growth

VISA SPONSORSHIP:

NuProbe is willing to sponsor H1-b work visa for the successful candidate

About NuProbe USA:

NuProbe USA is the US-based R&D subsidiary of NuProbe Global, a company that recently raised $62M YTD to develop novel non-invasive DNA. Its technology enables precise and comprehensive capturing of disease signatures with uniquely high sensitivity and multiplexing capability. NuProbe technologies can reduce the cost of NGS by 50-fold and improve the sensitivity of qPCR, Sanger, and nanopore sequencing by over 100-fold. NuProbe's technologies and products are globally recognized, and NuProbe has multiple partnerships with leading sequencing companies such as Illumina, Oxford Nanopore, and QIAGEN, and hospitals such as MD Anderson, Baylor College of Medicine, and Yale School of Medicine. As a global company, NuProbe also has a China site based in Shanghai and cGMP facility in Suzhou. NuProbe is co-founded by Prof. Peng Yin at Harvard University, David Zhang (former professor at Rice University), and Dr. Victor Shi (former founding president of Qiagen Asia.